Skip to main content
Tianjin Ringpu Bio-Technology Co.,Ltd. logo

Tianjin Ringpu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 300119 ISIN · CNE100000TV1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,285 across all filing types
Latest filing 2021-05-21 Major Shareholding Noti…
Country CN China
Listing Shenzhen Stock Exchange 300119

About Tianjin Ringpu Bio-Technology Co.,Ltd.

https://www.ringpu.com

Tianjin Ringpu Bio-Technology Co.,Ltd. is a high-tech enterprise specializing in the research, development, production, and sale of animal health products. The company offers a comprehensive portfolio that includes veterinary biological products, chemical drugs, feed additives, and pet health solutions. Its product range covers vaccines for poultry and livestock, as well as various pharmaceutical formulations such as injections, powders, and oral solutions. Ringpu Bio-Technology emphasizes innovation through its dedicated R&D centers, focusing on disease prevention and treatment to support the global animal husbandry industry. The company provides integrated health management services and high-quality veterinary medicines to ensure food safety and animal welfare.

Recent filings

Filing Released Lang Actions
关于控股股东部分股份解除质押和质押的公告
Major Shareholding Notification Classification · 95% confidence The document is a formal announcement from Tianjin Ruipu Biotechnology Co., Ltd. regarding the pledge and release of shares by the controlling shareholder Li Shoujun. It details the number of shares pledged and released, the proportion of shares involved, pledge dates, and pledgees. The document is short (1654 characters) and focuses solely on share pledge status and related shareholder information. There is no financial statement, earnings data, or management discussion. It is not a report but an announcement about share pledging activities by a major shareholder. This fits the category of Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels or related shareholding activities such as pledges. Therefore, the correct classification is MRQ with high confidence.
2021-05-21 Chinese
关于收到深圳证券交易所《关于天津瑞普生物技术股份有限公司申请向特定对象发行股票的审核问询函》的公告
Capital/Financing Update Classification · 95% confidence The document is a short announcement (675 characters) regarding the receipt of an inquiry letter from the Shenzhen Stock Exchange about the company's application for a private placement of shares. It mentions the company's intention to respond to the inquiry and that the issuance requires approval from the exchange and the China Securities Regulatory Commission. There is no detailed financial data or report content, only a regulatory update on the capital raising process. This fits the category of a Capital/Financing Update (CAP) rather than a full report or regulatory filing. The document is not a report publication announcement or certification, but a substantive update on financing activity.
2021-05-17 Chinese
北京市康达律师事务所关于天津瑞普生物技术股份有限公司2021年第一次临时股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the convening, attendance, voting procedures, and results of the 2021 first extraordinary general meeting (临时股东大会) of Tianjin Ruipu Biotechnology Co., Ltd. It details the legal compliance of the meeting process, the qualifications of attendees, and the voting outcomes. The document is not a report of financial results, audit, or management discussion, nor is it a notice or announcement of a report. It is a legal opinion related to a shareholder meeting, specifically focusing on the voting results and legality of the meeting procedures. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 3634 characters, which is sufficient to contain substantive content rather than a mere announcement. Therefore, the appropriate classification is DVA with high confidence.
2021-05-10 Chinese
关于举行投资者网上集体接待日活动的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement about an upcoming online investor reception day event hosted by the company. It includes details about the date, time, and participants but does not contain any financial data, report content, or regulatory filings. It is not a report itself but an event announcement for investors. Given the content and length, it does not fit into categories like Annual Report, Earnings Release, or Investor Presentation. It is best classified as a Regulatory Filing (RNS) since it is a general regulatory announcement that does not fit other specific categories.
2021-05-10 Chinese
关于2020年年度报告的更正公告
Regulatory Filings Classification · 95% confidence The document is titled as a correction announcement related to the company's 2020 Annual Report. It explicitly states that the original 2020 Annual Report was published earlier and this document serves to correct specific data within that report. The document length is 2126 characters, which is relatively short and consistent with a correction or announcement rather than the full annual report itself. The text includes corrected financial data tables and clarifies that other content remains unchanged. It also states that the corrected annual report is published alongside this announcement. Therefore, this document is not the full Annual Report (10-K) but a correction announcement related to it. Given the nature of the document as a correction notice to an annual report, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and correction notice, rather than the full Annual Report itself.
2021-05-10 Chinese
关于公司获得发明专利的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement from Tianjin Ruipu Biotechnology Co., Ltd. about obtaining an invention patent. It includes details about the patent and its significance but does not contain financial data, regulatory certifications, or meeting information. It is a regulatory announcement about intellectual property, not a financial report or meeting material. The document length is short (689 characters), and it is an announcement rather than a report. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2021-05-10 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.